Clinical trial · Observational
Fluid Balance During Surgery for Ovarian Cancer
Intraoperative Fluid Balance During Cytoreductive Surgery for Ovarian Cancer
NCT03006939CI-TRIAL-00025299unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Extensive tumour debulking challenges both surgeon and anaesthesiologist but promotes survival in late-stage ovarian cancer patients. Little is known about the intraoperative fluid balance and its impact on morbidity and mortality.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fluid Therapy | — | UNRESOLVED | — |
| Ovarian Neoplasm | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cytoreductive surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- fluid balance
- timeFrame
- at the end of surgery
- description
- intraoperative fluid balance is determined by the difference between fluid intake and outtake
Secondary outcomes (2)
- measure
- mechanical ventilation
- timeFrame
- at the timepoint of extubation
- description
- Duration of mechanical ventilation, starting from endotracheal intubation until extubation
- measure
- mortality
- timeFrame
- 5 years
- description
- long-term mortality after surgery
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients scheduled for cytoreductive surgery in ovarian cancer Exclusion Criteria: * Age \< 18 years * unability to give consent
References
Publications (0)
Data not yet available
No reference posted for this study.